Abstract CT029: Phase Ib study of GDC-6036 in combination with cetuximab in patients with colorectal cancer (CRC) with KRAS G12C mutation
暂无分享，去创建一个
J. Desai | S. Mandlekar | W. Miller | Yoonha Choi | A. Delmonte | R. Stec | E. Gort | S. Siena | M. Krebs | A. Cervantes | H. Prenen | E. Massarelli | Sae-Won Han | E. Garralda | A. Sacher | T. Karasic | Jong-Seok Lee | M. Patel | N. Dharia | Luis Paz-Arez | A. Falcón | S. Royer-Joo | R. Cosman | J. Schutzman | Mark T. Lin | T. W. Kim | Laura Medina | Martin D. Forster | E. Shacham-Shmueli | Kenneth K. Yau | Julie Chang